Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (6 ops.)
Latest filing published 05 Mar 2026 for NovoCure Ltd, €13k.
Filing timeline
BuySaleNicolas Leupin
Insider track record
Disclosed buys
0
Disclosed sells
6
Signal history
Nicolas Leupin: trading record in brief
Nicolas Leupin discloses dealings in Novocure Ltd to SEC (Form 4). Between 27 February 2024 and 4 March 2026, the trades on record add up to 8 filings.
On the market, this insider has only sold: 6 sales, €62k in total. Other entries cover 2 share grants. Since January 2026: no purchases and 2 sales on the market.
The latest filing, published on 5 March 2026, reports an open-market sale of €13k in Novocure Ltd. The median gap between a trade and its publication by SEC (Form 4) is 4 days. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Nicolas Leupin
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations6 total
1,100 shares@ US$13.30540.7% of flowOrdinary SharesSEC:0002007766-26-000003:0
1,029 shares@ US$13.66380.7% of flowOrdinary SharesSEC:0002007766-26-000002:0
54,975 shares@ US$18.1954.1% of flowOrdinary SharesSEC:0001562180-25-002163:0
830 shares@ US$19.92190.9% of flowOrdinary SharesSEC:0001562180-25-001836:0
830 shares@ US$19.92190.9% of flowOrdinary SharesSEC:0001562180-25-001913:0
51,124 shares@ US$16.3043.6% of flowOrdinary SharesSEC:0001562180-24-001985:0
6 of 6 declarations
